
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67607
Internal Medicine
Medical Education
Medical Simulation
Atypical Presentation of Hepatocellular Carcinoma in a Chronic Alcoholic: Diagnostic Challenges and Therapeutic Approach
Muacevic Alexander
Adler John R
Nunna Bhagyasri 1
Parihar Pratapsingh 1
Naseri Suhit 2
Dhabalia Rishabh 1
Bharadwaj Saraswathula 1
1 Radiodiagnosis, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND
2 Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND
Bhagyasri Nunna nunnabhagyasri999@gmail.com
23 8 2024
8 2024
16 8 e676078 6 2024
23 8 2024
Copyright © 2024, Nunna et al.
2024
Nunna et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/266052-atypical-presentation-of-hepatocellular-carcinoma-in-a-chronic-alcoholic-diagnostic-challenges-and-therapeutic-approach
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver, often arising in the context of chronic liver disease and cirrhosis. This case report describes the clinical presentation, diagnostic evaluation, and therapeutic intervention of a 72-year-old male with a long-standing history of alcohol use who presented with right hypochondrial pain. A 72-year-old male with a 20-year history of alcohol consumption presented with a one-month history of dull, aching pain in the right hypochondrium. Diagnostic imaging, including abdominal ultrasound and contrast-enhanced computed tomography (CECT), revealed significant hepatomegaly with nodular and irregular liver margins, free fluid in the abdomen and pelvis, and multiple hypodense nodules in both liver lobes. One nodule in the right lobe exhibited characteristic imaging features of hepatocellular carcinoma, including peripheral enhancement on the arterial phase and washout on the delayed phase. Histopathological analysis of a biopsy from the suspicious nodule confirmed the diagnosis of hepatocellular carcinoma. The patient was diagnosed with hepatocellular carcinoma based on clinical, radiological, and histopathological findings. He was subsequently scheduled for radiofrequency tumor ablation. This case underscores the importance of comprehensive diagnostic imaging and histopathological evaluation in patients with liver cirrhosis and suspected HCC, particularly in those with a history of chronic alcohol use.

histopathological evaluation
radiofrequency ablation
diagnostic imaging
alcohol-related liver disease
liver cirrhosis
hepatocellular carcinoma
==== Body
pmcIntroduction

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is responsible for a significant proportion of cancer-related deaths worldwide. It predominantly occurs in individuals with underlying chronic liver disease, particularly those with cirrhosis, which is often the result of chronic hepatitis B or C infection, non-alcoholic fatty liver disease (NAFLD), or chronic alcohol abuse [1,2]. Chronic alcohol consumption is a well-established risk factor for liver cirrhosis, which is a major precursor for the development of HCC. The pathogenesis of HCC in the context of alcohol-related liver disease is complex, involving repeated cycles of liver cell injury, inflammation, and regeneration, leading to genetic mutations and malignant transformation [3].

Early detection of HCC is critical for improving survival outcomes, as the disease often presents asymptomatically in its early stages and is frequently diagnosed at an advanced stage when curative treatment options are limited [4]. The diagnosis of HCC relies on clinical evaluation, imaging studies, and histopathological confirmation. Imaging modalities such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) play pivotal roles in detecting and characterizing hepatic lesions. Specifically, contrast-enhanced imaging techniques are essential for identifying the characteristic arterial phase hyperenhancement and delayed phase washout seen in HCC [5]. However, the presence of liver cirrhosis can complicate the interpretation of imaging findings due to the coexistence of benign lesions, such as regenerative and dysplastic nodules, which can mimic or obscure the presence of HCC [6].

Given the high risk of HCC in patients with cirrhosis, particularly those with a history of chronic alcohol use, routine surveillance with imaging and serum alpha-fetoprotein (AFP) levels is recommended for early detection [7]. Once diagnosed, the therapeutic approach to HCC depends on the stage of the disease, liver function, and overall patient health. Curative treatments, including surgical resection, liver transplantation, and ablative therapies, are most effective in early-stage HCC, whereas advanced-stage disease may require palliative treatments such as transarterial chemoembolization (TACE) or systemic therapy [8].

Case presentation

A 72-year-old male presented with a one-month history of dull, aching pain localized in the right hypochondrium. The patient has a 20-year history of alcohol use. Given the complaint of abdominal pain, an abdominal ultrasound was performed, revealing hepatomegaly with multiple isoechoic nodules. One nodule exhibited minimal vascularity on Doppler imaging. Subsequently, a contrast-enhanced computed tomography (CECT) scan of the abdomen and pelvis was conducted, which confirmed an enlarged liver measuring approximately 21 cm, indicative of hepatomegaly (Figure 1A). The liver margins appeared nodular and irregular, with the presence of free fluid in the abdomen (Figure 1B), suggestive of liver cirrhosis. Additionally, the pelvis detected free fluid (Figure 1C), consistent with ascites.

Figure 1 (A) A CT topogram shows an enlarged liver measuring 21 cm, indicative of hepatomegaly. (B) Contrast-enhanced CT (CECT) of the abdomen reveals nodular and irregular liver margins (white arrow), along with free fluid in the abdomen, suggestive of liver cirrhosis and ascites. (C) A CECT of the abdomen demonstrates free fluid in the pelvis (white arrow), suggestive of ascites.

The liver demonstrated multiple hypodense nodules showing peripheral enhancement in the arterial and venous phases, with no washout in the delayed phase across both lobes (Figure 2), suggesting dysplastic nodules. One nodule in the right lobe exhibited peripheral enhancement during the arterial phase (Figure 3A), which appeared isoattenuating during the venous phase (Figure 3B), and showed washout, appearing hypodense, during the delayed phase (Figure 3C). These contrast enhancement patterns across arterial, venous, and delayed phases are characteristic of hepatocellular carcinoma.

Figure 2 (A–C) A triple-phase CT abdomen shows multiple hypodense nodules showing peripheral enhancement on arterial and venous phases and no washout on the delayed phase in both the lobes of the liver, suggestive of dysplastic nodules.

Figure 3 (A) There is one suspicious nodule in the right lobe of the liver (white arrow), showing peripheral enhancement on the arterial phase of the CT abdomen. (B) The suspicious nodule appears isoattenuating on the venous phase of the CT abdomen. (C) The suspicious nodule shows washout and appears hypodense in the delayed phase. These patterns of contrast enhancement on the arterial, venous, and delayed phases of the contrast CT abdomen suggest hepatocellular carcinoma.

Consequently, a biopsy was recommended for the suspicious nodule. Histopathological examination with hematoxylin and eosin (H&E) staining at 40× magnification revealed tumor cells resembling hepatocytes, showing pleomorphism and forming two to eight cell-wide trabeculae separated by sinusoidal spaces. Widening of the hepatocellular plates was also noted (Figure 4), confirming the diagnosis of HCC. Based on the histopathological findings, the patient was scheduled for radiofrequency tumor ablation.

Figure 4 H&E 40× shows tumor cells resembling hepatocytes, which show pleomorphism and form two to eight cell-wide trabeculae, which are separated by sinusoidal spaces. There is a widening of hepatocellular plates, suggestive of hepatocellular carcinoma.

H&E: hematoxylin and eosin

Discussion

HCC is a prevalent malignancy that often arises in the context of chronic liver disease and cirrhosis, conditions frequently precipitated by chronic alcohol consumption. The insidious onset of HCC and its tendency to develop in a cirrhotic liver make early diagnosis challenging. In this case, the patient's chronic alcohol use, leading to cirrhosis, set the stage for the development of HCC, as evidenced by the radiological and histopathological findings. The association between chronic alcohol consumption and the development of liver cirrhosis is well documented. Alcohol-induced liver injury promotes hepatic fibrosis, eventually leading to cirrhosis, a major risk factor for HCC. According to the European Association for the Study of the Liver (EASL) guidelines, patients with liver cirrhosis, irrespective of etiology, are at an increased risk of developing HCC, and regular surveillance is recommended for early detection of this malignancy [5].

In this patient, the absence of classic symptoms of liver failure or HCC, such as jaundice or significant weight loss, exemplifies the atypical and subtle presentation of HCC in many cases, particularly in those with cirrhosis. Atypical presentations such as isolated right hypochondrial pain can often delay the diagnosis, emphasizing the importance of vigilant surveillance in high-risk patients [9]. Imaging modalities play a pivotal role in the diagnosis of HCC. The characteristic imaging features of HCC on CECT, including arterial phase hyperenhancement and washout in the venous or delayed phases, are critical for the diagnosis, particularly in cirrhotic livers, where lesions can be challenging to differentiate from benign nodules [1]. In this case, the CECT findings raised suspicion for HCC, which was subsequently confirmed by histopathology.

Histopathological confirmation remains the gold standard for HCC diagnosis. The typical histological features of HCC include trabecular patterns of tumor cells resembling hepatocytes, nuclear pleomorphism, and the widening of cell plates, as observed in this case. These findings corroborate the imaging diagnosis and provide a definitive diagnosis [10]. The therapeutic approach for HCC varies depending on the tumor stage, liver function, and overall patient condition. Radiofrequency ablation (RFA) was chosen as the treatment modality for this patient. RFA is a well-established, minimally invasive procedure for early-stage HCC, offering a curative option with a favorable safety profile in patients with cirrhosis [11]. This case highlights the diagnostic challenges posed by the subtle and atypical presentation of HCC in patients with chronic liver disease. It underscores the critical role of comprehensive imaging and histopathological evaluation in accurately diagnosing HCC, particularly in high-risk populations. Early detection through regular surveillance and appropriate therapeutic interventions can significantly improve outcomes for patients with HCC [12].

Conclusions

In conclusion, this case highlights the clinical presentation and diagnostic evaluation of a 72-year-old male with a history of chronic alcohol use who was diagnosed with HCC. The combination of imaging studies and histopathological examination provided a comprehensive assessment, revealing the presence of dysplastic nodules and hepatocellular carcinoma. The findings underscore the importance of early detection and the role of advanced imaging techniques in accurately diagnosing liver malignancies. Following the diagnosis, the patient was appropriately managed with a plan for radiofrequency tumor ablation, which represents a crucial step in the therapeutic approach for HCC. This case underscores the need for vigilant monitoring and timely intervention in patients with significant risk factors for liver cancer.

We acknowledge the valuable assistance provided by ChatGPT (OpenAI, San Francisco, California) in offering insightful suggestions for ensuring clarity and precision in our writing with Grammarly and Paperpal to enhance the quality and accuracy of our work.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Bhagyasri Nunna, Pratapsingh Parihar, Suhit Naseri, Rishabh Dhabalia, Saraswathula Bharadwaj

Acquisition, analysis, or interpretation of data:  Bhagyasri Nunna, Suhit Naseri

Drafting of the manuscript:  Bhagyasri Nunna

Critical review of the manuscript for important intellectual content:  Bhagyasri Nunna, Pratapsingh Parihar, Suhit Naseri, Rishabh Dhabalia, Saraswathula Bharadwaj
==== Refs
References

1 Hepatocellular carcinoma Lancet Forner A Reig M Bruix J 1301 1314 391 2018 29307467
2 Hepatocellular carcinoma N Engl J Med Villanueva A 1450 1462 380 2019 30970190
3 ACG clinical guideline: alcoholic liver disease Am J Gastroenterol Singal AK Bataller R Ahn J Kamath PS Shah VH 175 194 113 2018 29336434
4 Advances in targeted therapies for hepatocellular carcinoma in the genomic era Nat Rev Clin Oncol Llovet JM Villanueva A Lachenmayer A Finn RS 408 424 12 2015 26054909
5 EASL clinical practice guidelines: management of hepatocellular carcinoma J Hepatol European Association for the Study of the Liver 182 236 69 2018 29628281
6 Imaging diagnosis of hepatocellular carcinoma: future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound Clin Mol Hepatol Park J Lee JM Kim TH Yoon JH 362 379 28 2022 34955003
7 AASLD guidelines for the treatment of hepatocellular carcinoma Hepatology Heimbach JK Kulik LM Finn RS 358 380 67 2018 28130846
8 Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial Lancet Kudo M Finn RS Qin S 1163 1173 391 2018 29433850
9 Management of hepatocellular carcinoma: an update Hepatology Bruix J Sherman M 1020 1022 53 2011 21374666
10 Hepatocellular carcinoma: a review J Hepatocell Carcinoma Balogh J Victor D 3rd Asham EH 41 53 3 2016 27785449
11 Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology Livraghi T Meloni F Di Stasi M Rolle E Solbiati L Tinelli C Rossi S 82 89 47 2008 18008357
12 Molecular therapies and precision medicine for hepatocellular carcinoma Nat Rev Clin Oncol Llovet JM Montal R Sia D Finn RS 599 616 15 2018 30061739
